Brief: Syros Reports Fourth Quarter And Full Year 2022 Financial Results And Provides A Corporate Update

Syros Pharmaceuticals

02/03/2023 12:55

March 2 (Reuters) - Syros Pharmaceuticals Inc  SYRS.O :
    * SYROS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL
RESULTS AND PROVIDES A CORPORATE UPDATE
    * Q4 LOSS PER SHARE $0.17
    * COMMENCED RANDOMIZED PORTION OF SELECT-AML-1 TRIAL, WITH
INITIAL
DATA EXPECTED IN 4Q 2023
    * Q4 EARNINGS PER SHARE VIEW $-1.35 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw6kSzbVa 
Further company coverage:  SYRS.O